Leveraging a naturally occurring IgM autoantibody to target diabetogenic T cells: a precision medicine approach to type 1 diabetes
- 15 April 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (4)
Abstract
Current immunotherapies for autoimmune diseases lack sufficient specificity and often compromise protective immunity, underscoring the need for precision-based approaches. Here, we identify x-mAb, a germline-encoded IgM autoantibody derived from dual-expresser lymphocytes of patients with type 1 diabetes (T1D), as a potent agent for precision immunotherapy. In the nonobese diabetic mouse model, x-mAb prevents disease onset, induces durable remission, and preserves functional pancreatic islets without disrupting systemic immune homeostasis. Mechanistically, x-mAb selectively targets islet-reactive CD4 and CD8 tissue-resident memory (Trm) T cells in pancreas and pancreatic lymph nodes, as shown by MHC tetramer staining and in vivo tracking. x-mAb engagement downregulates CD69, a key Trm retention molecule, resulting in a marked reduction of pathogenic pancreatic T cells. Critically, x-mAb recognizes analogous CD69+ Trm-like peripheral T cells in T1D patients and downregulates CD69 ex vivo, indicating a conserved and therapeutically targetable mechanism across species. Structural modeling revealed that x-mAb engages TCRαβ through multiple contact sites, with the most stable interactions targeting a conserved CDR3α SGGGGS motif shared by diabetogenic human and mouse clonotypes. Based on these findings, we propose natural IgM autoantibodies as a previously unrecognized reservoir for precision biologics that selectively target autoreactive T cells while preserving immune competence.Keywords
This publication has 55 references indexed in Scilit:
- Effects of diabetic ketoacidosis, islet cell function, and age of onset on pancreas size, morphology, and exocrine function in children with type 1 diabetes: an abdominal MRI studyJournal of Endocrinological Investigation, 2025
- The role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implicationsAutoimmunity Reviews, 2025
- Islet‐Resident Memory T Cells Orchestrate the Immunopathogenesis of Type 1 Diabetes through the FABP4‐CXCL10 AxisAdvanced Science, 2024
- The shifting paradigm of a “cure” for type 1 diabetes: is technology replacing immune-based therapies?Acta Diabetologica, 2017
- Comparative Protein Structure Modeling Using MODELLERCurrent Protocols in Bioinformatics, 2016
- Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexesArthritis & Rheumatism, 2012
- Inhibition of Fas Ligand in NOD Mice Unmasks a Protective Role for IL-10 against Insulitis DevelopmentThe American Journal of Pathology, 2011
- T Cell Receptor Gene Polymorphisms Associated with Anti-Insulin, Autoimmune T Cells in Diabetes-Prone NOD MiceJournal of Autoimmunity, 1997
- Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDMDiabetologia, 1995
- Following a diabetogenic T cell from genesis through pathogenesisCell, 1993